These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 34251711)

  • 1. Local delivery of fingolimod through PLGA nanoparticles and PuraMatrix-embedded neural precursor cells promote motor function recovery and tissue repair in spinal cord injury.
    Zeraatpisheh Z; Mirzaei E; Nami M; Alipour H; Mahdavipour M; Sarkoohi P; Torabi S; Azari H; Aligholi H
    Eur J Neurosci; 2021 Aug; 54(4):5620-5637. PubMed ID: 34251711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pre-evaluated safe human iPSC-derived neural stem cells promote functional recovery after spinal cord injury in common marmoset without tumorigenicity.
    Kobayashi Y; Okada Y; Itakura G; Iwai H; Nishimura S; Yasuda A; Nori S; Hikishima K; Konomi T; Fujiyoshi K; Tsuji O; Toyama Y; Yamanaka S; Nakamura M; Okano H
    PLoS One; 2012; 7(12):e52787. PubMed ID: 23300777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significance of remyelination by neural stem/progenitor cells transplanted into the injured spinal cord.
    Yasuda A; Tsuji O; Shibata S; Nori S; Takano M; Kobayashi Y; Takahashi Y; Fujiyoshi K; Hara CM; Miyawaki A; Okano HJ; Toyama Y; Nakamura M; Okano H
    Stem Cells; 2011 Dec; 29(12):1983-94. PubMed ID: 22028197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transplantation of neural stem/progenitor cells at different locations in mice with spinal cord injury.
    Iwai H; Nori S; Nishimura S; Yasuda A; Takano M; Tsuji O; Fujiyoshi K; Toyama Y; Okano H; Nakamura M
    Cell Transplant; 2014; 23(11):1451-64. PubMed ID: 23998989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rehabilitative Training Enhances Therapeutic Effect of Human-iPSC-Derived Neural Stem/Progenitor Cells Transplantation in Chronic Spinal Cord Injury.
    Shibata T; Tashiro S; Shibata S; Shinozaki M; Shindo T; Hashimoto S; Kawai M; Kitagawa T; Ago K; Matsumoto M; Nakamura M; Okano H; Nagoshi N
    Stem Cells Transl Med; 2023 Mar; 12(2):83-96. PubMed ID: 36647673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polarized Macrophages Have Distinct Roles in the Differentiation and Migration of Embryonic Spinal-cord-derived Neural Stem Cells After Grafting to Injured Sites of Spinal Cord.
    Zhang K; Zheng J; Bian G; Liu L; Xue Q; Liu F; Yu C; Zhang H; Song B; Chung SK; Ju G; Wang J
    Mol Ther; 2015 Jun; 23(6):1077-1091. PubMed ID: 25794051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A robust culture system to generate neural progenitors with gliogenic competence from clinically relevant induced pluripotent stem cells for treatment of spinal cord injury.
    Kamata Y; Isoda M; Sanosaka T; Shibata R; Ito S; Okubo T; Shinozaki M; Inoue M; Koya I; Shibata S; Shindo T; Matsumoto M; Nakamura M; Okano H; Nagoshi N; Kohyama J
    Stem Cells Transl Med; 2021 Mar; 10(3):398-413. PubMed ID: 33226180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improvement of Rat Spinal Cord Injury Following Lentiviral Vector-Transduced Neural Stem/Progenitor Cells Derived from Human Epileptic Brain Tissue Transplantation with a Self-assembling Peptide Scaffold.
    Abdolahi S; Aligholi H; Khodakaram-Tafti A; Khaleghi Ghadiri M; Stummer W; Gorji A
    Mol Neurobiol; 2021 Jun; 58(6):2481-2493. PubMed ID: 33443682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neural stem/progenitor cell-laden microfibers promote transplant survival in a mouse transected spinal cord injury model.
    Sugai K; Nishimura S; Kato-Negishi M; Onoe H; Iwanaga S; Toyama Y; Matsumoto M; Takeuchi S; Okano H; Nakamura M
    J Neurosci Res; 2015 Dec; 93(12):1826-38. PubMed ID: 26301451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparing neural stem/progenitor cells in PuraMatrix hydrogel for transplantation after brain injury in rats: A comparative methodological study.
    Aligholi H; Rezayat SM; Azari H; Ejtemaei Mehr S; Akbari M; Modarres Mousavi SM; Attari F; Alipour F; Hassanzadeh G; Gorji A
    Brain Res; 2016 Jul; 1642():197-208. PubMed ID: 27038753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined application of neural stem/progenitor cells and scaffolds on locomotion recovery following spinal cord injury in rodents: a systematic review and meta-analysis.
    Yousefifard M; Askarian-Amiri S; Nasseri Maleki S; Rafiei Alavi SN; Madani Neishaboori A; Haghani L; Vaccaro AR; Harrop JS; Lu Y; Rahimi-Movaghar V; Hosseini M
    Neurosurg Rev; 2022 Dec; 45(6):3469-3488. PubMed ID: 36114918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of FTY720 on Neural Cell Behavior in Two and Three-Dimensional Culture and in Compression Spinal Cord Injury.
    Zeraatpisheh Z; Shamsi F; Sarkoohi P; Torabi S; Alipour H; Aligholi H
    Cell Mol Bioeng; 2022 Aug; 15(4):331-340. PubMed ID: 36119134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sustained intraspinal delivery of neurotrophic factor encapsulated in biodegradable nanoparticles following contusive spinal cord injury.
    Wang YC; Wu YT; Huang HY; Lin HI; Lo LW; Tzeng SF; Yang CS
    Biomaterials; 2008 Dec; 29(34):4546-53. PubMed ID: 18774604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allogeneic Neural Stem/Progenitor Cells Derived From Embryonic Stem Cells Promote Functional Recovery After Transplantation Into Injured Spinal Cord of Nonhuman Primates.
    Iwai H; Shimada H; Nishimura S; Kobayashi Y; Itakura G; Hori K; Hikishima K; Ebise H; Negishi N; Shibata S; Habu S; Toyama Y; Nakamura M; Okano H
    Stem Cells Transl Med; 2015 Jul; 4(7):708-19. PubMed ID: 26019226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design and optimization of PLGA microparticles for controlled and local delivery of Neuregulin-1 in traumatic spinal cord injury.
    Santhosh KT; Alizadeh A; Karimi-Abdolrezaee S
    J Control Release; 2017 Sep; 261():147-162. PubMed ID: 28668379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Administration of C5a Receptor Antagonist Improves the Efficacy of Human Induced Pluripotent Stem Cell-Derived Neural Stem/Progenitor Cell Transplantation in the Acute Phase of Spinal Cord Injury.
    Shibata R; Nagoshi N; Kajikawa K; Ito S; Shibata S; Shindo T; Khazaei M; Nori S; Kohyama J; Fehlings MG; Matsumoto M; Nakamura M; Okano H
    J Neurotrauma; 2022 May; 39(9-10):667-682. PubMed ID: 35196890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Time-dependent changes in the microenvironment of injured spinal cord affects the therapeutic potential of neural stem cell transplantation for spinal cord injury.
    Nishimura S; Yasuda A; Iwai H; Takano M; Kobayashi Y; Nori S; Tsuji O; Fujiyoshi K; Ebise H; Toyama Y; Okano H; Nakamura M
    Mol Brain; 2013 Jan; 6():3. PubMed ID: 23298657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acellular Spinal Cord Scaffold Implantation Promotes Vascular Remodeling with Sustained Delivery of VEGF in a Rat Spinal Cord Hemisection Model.
    Xu ZX; Zhang LQ; Wang CS; Chen RS; Li GS; Guo Y; Xu WH
    Curr Neurovasc Res; 2017; 14(3):274-289. PubMed ID: 28721809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transplantation of galectin-1-expressing human neural stem cells into the injured spinal cord of adult common marmosets.
    Yamane J; Nakamura M; Iwanami A; Sakaguchi M; Katoh H; Yamada M; Momoshima S; Miyao S; Ishii K; Tamaoki N; Nomura T; Okano HJ; Kanemura Y; Toyama Y; Okano H
    J Neurosci Res; 2010 May; 88(7):1394-405. PubMed ID: 20091712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative study of methods for administering neural stem/progenitor cells to treat spinal cord injury in mice.
    Takahashi Y; Tsuji O; Kumagai G; Hara CM; Okano HJ; Miyawaki A; Toyama Y; Okano H; Nakamura M
    Cell Transplant; 2011; 20(5):727-39. PubMed ID: 21054930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.